Knockdown of Chloride Channel-3 Inhibits Breast Cancer GrowthIn VitroandIn Vivo

Fang-Min Zhou,Yun-Ying Huang,Tian,Xiao-Yan Li,Yong-Bo Tang
DOI: https://doi.org/10.4048/jbc.2018.21.2.103
2018-01-01
Abstract:Purpose: Chloride channel-3 (CIC-3) is a member of the chloride channel family and plays a critical role in a variety of cellular activities. The aim of the present study is to explore the molecular mechanisms underlying the antitumor effect of silencing CIC-3 in breast cancer. Methods: Human breast cancer cell lines MDAMB-231 and MCF-7 were used in the experiments. Messenger RNA and protein expression were examined by quantitative realtime polymerase chain reaction and western blot analysis. Cell proliferation was measured by the bromodeoxyuridine method, and the cell cycle was evaluated using fluorescence-activated cell sorting. Protein interaction in cells was analyzed by co-immunoprecipitation. Tumor tissues were stained with hematoxylin-eosin and tumor burden was measured using the Metamorph software. Results: Breast cancer tissues collected from patients showed an increase in CIC-3 expression. Knockdown of CIC-3 inhibited the secretion of insulin-like growth factor (IGF)-1, cell proliferation, and G1/S transition in breast cancer cells. In the mouse xenograft model of human breast carcinoma, tumor growth was significantly slower in animals injected with CIC-3-deficient cells compared with the growth of normal human breast cancer cells. In addition, silencing of CIC-3 attenuated the expression of proliferating cell nuclear antigen, Ki-67, cyclin D1, and cyclin E, as well as the activation of extracellular signal-regulated protein kinases (ERK) 1/2, both in vitro and in vivo. Conclusion: Together, our data suggest that upregulation of CIC-3 by IGF-1 contributes to cell proliferation and tumor growth in breast cancer, and CIC-3 deficiency suppresses cell proliferation and tumor growth via the IGF/IGF receptor/ERK pathway.
What problem does this paper attempt to address?